News and Trends 19 Sep 2022
GENFIT to acquire Versantis to expand liver disease portfolio
GENFIT has entered into an exclusivity agreement with a view to acquire all the share capital and voting rights of Versantis, a private Swiss-based clinical stage biotechnology company focused on…